Aktie A3EVTZ CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Regenerative Medicine International Limited

Aktien

A3EVTZ

KYG2129W1380

8158

Verzögert Hong Kong S.E.
Andere Börsenplätze
 03:39:55 30.04.2024 		% 5 Tage % 1. Jan.
0,275 HKD -3,51 % Intraday Chart für China Regenerative Medicine International Limited -1,79 % -50,00 %
02.04. China Regenerative Medicine International Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 China Regenerative Medicine International Limited meldet die Ergebnisse für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
China Regenerative Medicine International Limited Announces CFO Change
China Regenerative Medicine International Limited Announces Executive Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2021
China Regenerative Medicine International Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021
China Regenerative Medicine International Limited Announces Board Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
China Regenerative Medicine International Limited Announces Executive Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
China Regenerative Medicine International Limited Announces the Cessation of Lee Pak Chung as Chief Financial Officer
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2020
China Regenerative Medicine International Limited Enters into Non-Legally Binding Memorandum of Understanding with Jinxin Holdings Co, Ltd
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EVTZ Aktie
  4. Nachrichten China Regenerative Medicine International Limited
  5. Andere Sprachen